Journal article

Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling


Authors listKojonazarov, Baktybek; Sydykov, Akylbek; Pullamsetti, Soni Savai; Luitel, Himal; Dahal, Bhola K.; Kosanovic, Djuro; Tian, Xia; Majewski, Matthaeus; Baumann, Christin; Evans, Steve; Phillips, Peter; Fairman, David; Davie, Neil; Wayman, Chris; Kilty, Iain; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo

Publication year2013

Pages2630-2637

JournalInternational Journal of Cardiology

Volume number167

Issue number6

ISSN0167-5273

eISSN1874-1754

DOI Linkhttps://doi.org/10.1016/j.ijcard.2012.06.129

PublisherElsevier


Abstract

Background: Little is known about the effects of current PAH therapies and receptor tyrosine kinase inhibitors on heart remodeling. We sought to investigate the effects of the multikinase inhibitors sunitinib (PDGFR-, VEGFR- and KIT-inhibitor) and sorafenib (raf1/b-, VEGFR-, PDGFR-inhibitor) on pressure overload induced right ventricular (RV) remodeling.

Methods: We investigated the effects of the kinase inhibitors on hemodynamics and remodeling in rats subjected either to monocrotaline (MCT)-induced PH or to surgical pulmonary artery banding (PAB). MCT rats were treated from days 21 to 35 with either vehicle, sunitinib (1 mg/kg, 5 mg/kg and 10 mg/kg/day) or sorafenib (10 mg/kg/day). PAB rats were treated with vehicle, sunitinib (10 mg/kg/day) or sorafenib (10 mg/kg/day) from days 7 to 21. RV function and remodeling were determined using echocardiography, invasive hemodynamic measurement and histomorphometry.

Results: Treatment with both sorafenib and sunitinib decreased right ventricular systolic pressure, pulmonary vascular remodeling, RV hypertrophy and fibrosis in MCT rats. This was associated with an improvement of RV function. Importantly, after PAB, both compounds reversed RV chamber and cellular hypertrophy, reduced RV interstitial and perivascular fibrosis, and improved RV function.

Conclusion: We demonstrated that sunitinib and sorafenib reversed RV remodeling and significantly improved RV function measured via a range of invasive and non-invasive cardiopulmonary endpoints in experimental models of RV hypertrophy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.




Citation Styles

Harvard Citation styleKojonazarov, B., Sydykov, A., Pullamsetti, S., Luitel, H., Dahal, B., Kosanovic, D., et al. (2013) Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling, International Journal of Cardiology, 167(6), pp. 2630-2637. https://doi.org/10.1016/j.ijcard.2012.06.129

APA Citation styleKojonazarov, B., Sydykov, A., Pullamsetti, S., Luitel, H., Dahal, B., Kosanovic, D., Tian, X., Majewski, M., Baumann, C., Evans, S., Phillips, P., Fairman, D., Davie, N., Wayman, C., Kilty, I., Weissmann, N., Grimminger, F., Seeger, W., Ghofrani, H., ...Schermuly, R. (2013). Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling. International Journal of Cardiology. 167(6), 2630-2637. https://doi.org/10.1016/j.ijcard.2012.06.129



Keywords


ARTERIAL-HYPERTENSIONCELL APOPTOSISENDOTHELIAL GROWTH-FACTOREXPERIMENTAL PULMONARY-HYPERTENSIONFACTOR RECEPTORPulmonary hypertensionright ventricular remodelingSORAFENIBSU11248SunitinibTYROSINE

Last updated on 2025-21-05 at 18:38